See more : ZOZO, Inc. (3092.T) Income Statement Analysis – Financial Results
Complete financial analysis of Hapvida Participações e Investimentos S.A. (HAPV3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hapvida Participações e Investimentos S.A., a leading company in the Insurance – Specialty industry within the Financial Services sector.
- Norinco International Cooperation Ltd. (000065.SZ) Income Statement Analysis – Financial Results
- The People’s Insurance Company (Group) of China Limited (601319.SS) Income Statement Analysis – Financial Results
- Sparx Holdings Group, Inc. (PRTM) Income Statement Analysis – Financial Results
- Tidewater Inc. (TDW-WT) Income Statement Analysis – Financial Results
- Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi (AEBZY) Income Statement Analysis – Financial Results
Hapvida Participações e Investimentos S.A. (HAPV3.SA)
About Hapvida Participações e Investimentos S.A.
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers medical and dental insurance plans. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services, as well as organizes courses, lectures, seminars, and other events. In addition, the company engages in the administration, advisory, implementation, and sale of individual, family, and collective health care systems and plans; and reimbursement of medical, dental, hospital, and healthcare expenses to its beneficiaries, as well as provides medical and hospital care services. The company operates a network of 85 hospitals, 77 emergency units, 318 clinics, and 269 diagnostic units. The company was founded in 1979 and is based in Fortaleza, Brazil.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 27.38B | 23.75B | 9.88B | 8.55B | 5.63B | 4.58B | 3.85B | 3.04B | 2.46B | 1.96B |
Cost of Revenue | 20.31B | 18.09B | 6.82B | 5.21B | 3.40B | 2.75B | 2.24B | 1.86B | 1.50B | 1.19B |
Gross Profit | 7.07B | 5.66B | 3.07B | 3.35B | 2.23B | 1.82B | 1.61B | 1.17B | 958.59M | 772.18M |
Gross Profit Ratio | 25.81% | 23.81% | 31.02% | 39.11% | 39.65% | 39.80% | 41.82% | 38.64% | 38.98% | 39.33% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 785.80M | 1.21B | 582.51M | 357.97M | 371.57M | 273.76M | 449.85M | 368.01M | 361.19M | 229.21M |
Selling & Marketing | 1.39B | 1.30B | 514.21M | 449.27M | 352.76M | 294.73M | 378.18M | 334.42M | 266.93M | 189.70M |
SG&A | 2.18B | 2.51B | 1.10B | 807.24M | 724.33M | 568.49M | 828.02M | 702.43M | 628.11M | 436.63M |
Other Expenses | 4.89B | 3.31B | 1.43B | 1.18B | 399.93M | -129.00K | 7.72M | 3.53M | 9.04M | 0.00 |
Operating Expenses | 7.07B | 5.82B | 2.52B | 1.99B | 1.12B | 960.80M | 835.74M | 705.97M | 637.15M | 521.57M |
Cost & Expenses | 27.38B | 23.91B | 9.34B | 7.19B | 4.52B | 3.72B | 3.07B | 2.57B | 2.14B | 1.71B |
Interest Income | 340.96M | 751.11M | 14.73M | 14.02M | 21.77M | 1.06M | 419.00K | 283.00K | 351.00K | 37.51M |
Interest Expense | 1.76B | 1.61B | 234.15M | 149.57M | 123.32M | 644.00K | 1.39M | 2.80M | 1.39M | 0.00 |
Depreciation & Amortization | 2.13B | 2.19B | 895.08M | 752.49M | 199.84M | 42.46M | 40.99M | 20.69M | 21.65M | 18.53M |
EBITDA | 3.22B | 2.43B | 1.65B | 2.05B | 1.47B | 1.09B | 946.56M | 616.18M | 407.47M | 362.75M |
EBITDA Ratio | 11.74% | 10.30% | 16.59% | 24.68% | 27.14% | 19.73% | 21.17% | 16.07% | 13.95% | 18.47% |
Operating Income | 1.46B | 259.96M | 744.69M | 1.36B | 1.33B | 860.43M | 783.45M | 469.88M | 326.69M | 344.22M |
Operating Income Ratio | 5.33% | 1.09% | 7.53% | 15.88% | 23.60% | 18.80% | 20.36% | 15.47% | 13.29% | 17.53% |
Total Other Income/Expenses | -2.13B | -1.71B | -251.81M | -227.90M | -200.00M | 171.82M | 111.54M | 115.54M | 50.67M | -56.10M |
Income Before Tax | -673.72M | -1.45B | 492.88M | 1.13B | 1.13B | 1.04B | 895.00M | 585.42M | 377.36M | 288.12M |
Income Before Tax Ratio | -2.46% | -6.10% | 4.99% | 13.24% | 20.05% | 22.78% | 23.26% | 19.28% | 15.35% | 14.67% |
Income Tax Expense | 66.17M | -671.97M | -7.46M | 347.36M | 277.63M | 254.00M | 244.40M | 128.93M | 66.03M | 18.68M |
Net Income | -739.77M | -775.84M | 497.80M | 783.46M | 849.83M | 787.47M | 648.77M | 457.12M | 301.24M | 270.09M |
Net Income Ratio | -2.70% | -3.27% | 5.04% | 9.16% | 15.08% | 17.21% | 16.86% | 15.05% | 12.25% | 13.76% |
EPS | -0.10 | -0.11 | 0.13 | 0.21 | 0.22 | 0.23 | 0.23 | 0.16 | 0.11 | 4.30 |
EPS Diluted | -0.10 | -0.11 | 0.13 | 0.21 | 0.22 | 0.23 | 0.23 | 0.16 | 0.11 | 4.30 |
Weighted Avg Shares Out | 7.51B | 6.84B | 3.84B | 3.71B | 3.86B | 3.36B | 2.80B | 4.76B | 4.76B | 62.83M |
Weighted Avg Shares Out (Dil) | 7.51B | 6.84B | 3.84B | 3.71B | 3.86B | 3.36B | 2.80B | 4.76B | 4.76B | 62.83M |
Source: https://incomestatements.info
Category: Stock Reports